Adjuvant chemotherapy in older women with early-stage breast cancer

Authors :: Muss, Hyman B.
Berry, Donald A.
Cirrincione, Constance T.
Theodoulou, Maria
Mauer, Ann M.
Kornblith, Alice B.
Partridge, Ann H.
Dressler, Lynn G.
Cohen, Harvey J.
Becker, Heather P.
Kartcheske, Patricia A.
Wheeler, Judith D.
Perez, Edith A.
Wolff, Antonio C.
Gralow, Julie R.
Burstein, Harold J.
Mahmood, Ahmad A.
Magrinat, Gustav
Parker, Barbara A.
Hart, Ronald D.
Grenier, Debjani
Norton, Larry
Hudis, Clifford A.
Winer, Eric P.
Source :: The New England Journal of Medicine. May 14, 2009, Vol. 360 Issue 20, p2055, 11 p.
Publication Year :: 2009
Abstract: A study was conducted to evaluate the benefits of adjuvant chemotherapy among older women with breast cancer aged 65 years or above as compared to other standard chemotherapies. Results indicated that adjuvant chemotherapy was found to be more effective among older women as compared to other standards forms like capecitabine.

Subjects :: Breast cancer -- Care and treatment
Capecitabine -- Usage
Capecitabine -- Comparative analysis
Aged women -- Health aspects
Cancer -- Adjuvant treatment
Cancer -- Comparative analysis
Cancer -- Evaluation

Tools